CN113614539A - 一种粘液病毒抗性蛋白1的定量试剂盒 - Google Patents
一种粘液病毒抗性蛋白1的定量试剂盒 Download PDFInfo
- Publication number
- CN113614539A CN113614539A CN202080024112.4A CN202080024112A CN113614539A CN 113614539 A CN113614539 A CN 113614539A CN 202080024112 A CN202080024112 A CN 202080024112A CN 113614539 A CN113614539 A CN 113614539A
- Authority
- CN
- China
- Prior art keywords
- resistance protein
- buffer solution
- myxovirus resistance
- antibody
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100031802 Interferon-induced GTP-binding protein Mx1 Human genes 0.000 title claims abstract description 37
- 101710202180 Interferon-induced GTP-binding protein Mx1 Proteins 0.000 title claims abstract description 26
- 239000002245 particle Substances 0.000 claims abstract description 23
- 239000004816 latex Substances 0.000 claims abstract description 22
- 229920000126 latex Polymers 0.000 claims abstract description 22
- 239000007853 buffer solution Substances 0.000 claims description 23
- 239000003153 chemical reaction reagent Substances 0.000 claims description 20
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 13
- 239000004471 Glycine Substances 0.000 claims description 8
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000701 coagulant Substances 0.000 claims description 4
- 239000008118 PEG 6000 Substances 0.000 claims description 3
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 3
- -1 amino, hydroxyl Chemical group 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- SFRDXVJWXWOTEW-UHFFFAOYSA-N 2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)CO SFRDXVJWXWOTEW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 241000282693 Cercopithecidae Species 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 241000282898 Sus scrofa Species 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000007982 barbital buffer Substances 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 125000003636 chemical group Chemical group 0.000 claims description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 238000003908 quality control method Methods 0.000 claims description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 2
- 229940033663 thimerosal Drugs 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 claims description 2
- 229960000281 trometamol Drugs 0.000 claims description 2
- 238000011002 quantification Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 7
- 238000002835 absorbance Methods 0.000 abstract description 7
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 abstract description 2
- 210000003097 mucus Anatomy 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 101001128393 Homo sapiens Interferon-induced GTP-binding protein Mx1 Proteins 0.000 description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- 102000006992 Interferon-alpha Human genes 0.000 description 3
- 108010047761 Interferon-alpha Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 101000852870 Homo sapiens Interferon alpha/beta receptor 1 Proteins 0.000 description 1
- 101000852865 Homo sapiens Interferon alpha/beta receptor 2 Proteins 0.000 description 1
- 102100036714 Interferon alpha/beta receptor 1 Human genes 0.000 description 1
- 102100036718 Interferon alpha/beta receptor 2 Human genes 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 108010083736 Myxovirus Resistance Proteins Proteins 0.000 description 1
- 102000006421 Myxovirus Resistance Proteins Human genes 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000002726 cyst fluid Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
涉及一种粘液病毒抗性蛋白1的定量试剂盒。具体而言，公开了一种试剂盒，其包含包被有粘液病毒抗性蛋白1抗体的胶乳颗粒。利用人血清、血浆样本中粘液病毒抗性蛋白1和交联有粘液病毒抗性蛋白1抗体的胶乳颗粒，特异性结合形成复合物，从而导致吸光度升高，通过检测免疫浊度的变化，达到较高的灵敏度和较宽的检测范围。
Description
PCT国内申请，说明书已公开。
Claims (3)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010063962 | 2020-01-20 | ||
| CN2020100639627 | 2020-01-20 | ||
| PCT/CN2020/126382 WO2021147453A1 (zh) | 2020-01-20 | 2020-11-04 | 一种粘液病毒抗性蛋白1的定量试剂盒 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113614539A true CN113614539A (zh) | 2021-11-05 |
Family
ID=76992818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080024112.4A Pending CN113614539A (zh) | 2020-01-20 | 2020-11-04 | 一种粘液病毒抗性蛋白1的定量试剂盒 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230049153A1 (zh) |
| JP (1) | JP2023510202A (zh) |
| CN (1) | CN113614539A (zh) |
| WO (1) | WO2021147453A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113671175A (zh) * | 2021-09-07 | 2021-11-19 | 普十生物科技(北京)有限公司 | 一种检测血栓素b2的试剂及试剂盒 |
| CN114878825A (zh) * | 2022-03-29 | 2022-08-09 | 北京世纪沃德生物科技有限公司 | 一种c肽测定试剂盒及人血清中c肽含量的检测方法 |
| CN117250356B (zh) * | 2023-05-23 | 2024-02-20 | 安徽千诚生物技术有限公司 | 一种定量检测可溶性st2蛋白的胶乳增强免疫比浊试剂盒及其制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1630557A1 (de) * | 2004-08-27 | 2006-03-01 | Institut Virion/Serion GmbH | Diagnostisches Testsystem für den Nachweis von Antikörpern gegen das Epstein Barr Virus (EBV) |
| CN102662061A (zh) * | 2012-04-17 | 2012-09-12 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 |
| CN105223356A (zh) * | 2015-10-20 | 2016-01-06 | 常州英赞美科生物科技有限公司 | Gpi胶乳增强免疫比浊法体外定量测定诊断试剂盒 |
| CN108445233A (zh) * | 2018-04-10 | 2018-08-24 | 安徽金标点生物科技有限公司 | 一种抗病毒蛋白MxA诊断试剂盒及其制备方法 |
| CN109725152A (zh) * | 2018-12-13 | 2019-05-07 | 厦门万泰凯瑞生物技术有限公司 | 一种抗病毒蛋白MxA微粒子化学发光免疫分析检测试剂盒 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130196310A1 (en) * | 2008-05-20 | 2013-08-01 | Rapid Pathogen Screening, Inc. | Method and Device for Combined Detection of Viral and Bacterial Infections |
| US9709565B2 (en) * | 2010-04-21 | 2017-07-18 | Memed Diagnostics Ltd. | Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof |
| CN110988363A (zh) * | 2019-12-31 | 2020-04-10 | 苏州康和顺医疗技术有限公司 | 一种抗病毒蛋白MxA的检测试剂及其制备方法 |
-
2020
- 2020-11-04 CN CN202080024112.4A patent/CN113614539A/zh active Pending
- 2020-11-04 WO PCT/CN2020/126382 patent/WO2021147453A1/zh active Application Filing
- 2020-11-04 US US17/790,479 patent/US20230049153A1/en active Pending
- 2020-11-04 JP JP2022540739A patent/JP2023510202A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1630557A1 (de) * | 2004-08-27 | 2006-03-01 | Institut Virion/Serion GmbH | Diagnostisches Testsystem für den Nachweis von Antikörpern gegen das Epstein Barr Virus (EBV) |
| CN102662061A (zh) * | 2012-04-17 | 2012-09-12 | 北京九强生物技术股份有限公司 | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 |
| CN105223356A (zh) * | 2015-10-20 | 2016-01-06 | 常州英赞美科生物科技有限公司 | Gpi胶乳增强免疫比浊法体外定量测定诊断试剂盒 |
| CN108445233A (zh) * | 2018-04-10 | 2018-08-24 | 安徽金标点生物科技有限公司 | 一种抗病毒蛋白MxA诊断试剂盒及其制备方法 |
| CN109725152A (zh) * | 2018-12-13 | 2019-05-07 | 厦门万泰凯瑞生物技术有限公司 | 一种抗病毒蛋白MxA微粒子化学发光免疫分析检测试剂盒 |
Non-Patent Citations (2)
| Title |
|---|
| ROBERT SAMBURSKY等: "Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection", 《EUROPEN CLINICLA RESPIRATORY JOURNAL》, no. 2015, pages 2 * |
| 徐建新主编: "智慧即时检测iPOCT", 30 June 2016, 上海科学技术出版社, pages: 26 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021147453A1 (zh) | 2021-07-29 |
| US20230049153A1 (en) | 2023-02-16 |
| JP2023510202A (ja) | 2023-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113614539A (zh) | 一种粘液病毒抗性蛋白1的定量试剂盒 | |
| CN102759631B (zh) | 一种定量检测降钙素原pct的胶乳增强免疫比浊试剂盒 | |
| CN109738626B (zh) | Ngal胶乳免疫比浊法检测试剂盒及其制备方法 | |
| CN111751544B (zh) | 一种用于检测可溶性生长激素表达基因2蛋白的试剂盒 | |
| CN109596843B (zh) | 一种血清淀粉样蛋白a的测定试剂盒 | |
| CN112782156B (zh) | 一种壳多糖酶3样蛋白1试剂盒及其制备方法 | |
| CN110806487A (zh) | 一种用于人肝素结合蛋白检测的试剂盒及其制备方法 | |
| WO2021088730A1 (zh) | 游离前列腺特异性抗原检测试剂盒及其制备方法 | |
| CN202916286U (zh) | 一种定量检测降钙素原pct的胶乳增强免疫比浊试剂盒 | |
| CN107589266A (zh) | 一种血管内皮生长因子胶乳增强免疫比浊试剂盒及其应用 | |
| CN111089958A (zh) | 一种基于葡聚糖信号放大的p16INK4a化学发光试剂盒 | |
| CN114814214A (zh) | 一种胶体金、乳胶微球标记联合的星状病毒免疫层析检测试剂盒及制备方法 | |
| CN107271692B (zh) | 一种标记特异性高亲和力重组抗体的荧光微球及其应用 | |
| CN113687079A (zh) | 一种胃蛋白酶原ⅰ胶乳免疫比浊法检测试剂盒及其制备方法 | |
| CN108362892B (zh) | 一种降钙素原胶体金免疫比浊法检测试剂 | |
| CN105891497A (zh) | 一种降钙素原胶体金免疫比色法定量检测试剂盒及其制备方法 | |
| CN106556699B (zh) | 用于测定豆荚蛋白的血液水平的方法和组合物 | |
| CN114578050A (zh) | 新型冠状病毒抗体的检测试剂及其制备方法 | |
| CN112129933B (zh) | 一种免疫分析系统中抗生物素干扰的试剂、试剂盒及方法 | |
| CN113777326A (zh) | 一种高特异检测肝素结合蛋白的试剂盒及其应用 | |
| CN113189343A (zh) | 一种同时检测血清和尿液中视黄醇结合蛋白的试剂盒 | |
| CN111269310B (zh) | C-p串联表达重组蛋白及其基因、制备方法、应用、c肽检测试剂盒 | |
| CN112730827A (zh) | 一种新型冠状病毒抗体检测试剂盒及其制备方法 | |
| CN115656518A (zh) | 一种测定人血浆和尿液中肝素结合蛋白的检测试剂盒 | |
| CN116840489A (zh) | 户尘螨过敏原特异性IgE抗体检测试剂盒及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |